Ftse Mib
33.483,31
-0,90%
DAX
19.822,61
-0,88%
S&P 500
5.867,08
-0,09%
NASDAQ
19.372,77
-0,10%
Bitcoin
96.723,07
-0,75%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Avidity Biosciences Inc (RNA) Avidity Biosciences Inc (RNA) Notizie

Avidity Biosciences Inc

RNA
31,05
0,00 (0,00%)
20 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:29EDGAR2Form 144 - Report of proposed sale of securities
14/12/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:59EDGAR2Form 144 - Report of proposed sale of securities
26/11/202416:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
21/11/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
21/11/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202415:39EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202422:40EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202413:06EDGAR2Form 8-K - Current report
12/11/202413:00PRNUSAvidity Biosciences Announces New Precision Cardiology..
07/11/202422:09EDGAR2Form 8-K - Current report
07/11/202422:05PRNUSAvidity Biosciences Reports Third Quarter 2024 Financial..
31/10/202414:00PRNUSAvidity Biosciences to Host Investor and Analyst Event..
30/10/202413:01EDGAR2Form 8-K - Current report
30/10/202413:00PRNUSAvidity Biosciences Pursues Potential Accelerated Approval..
21/10/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
17/10/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202413:02EDGAR2Form 8-K - Current report
03/10/202413:00PRNUSAvidity Biosciences Announces FDA Removed Partial Clinical..
01/10/202422:36EDGAR2Form 144 - Report of proposed sale of securities
25/9/202415:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
24/9/202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/9/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/9/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202422:27EDGAR2Form 144 - Report of proposed sale of securities
23/9/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
13/9/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202422:18EDGAR2Form 144 - Report of proposed sale of securities
11/9/202422:18EDGAR2Form 144 - Report of proposed sale of securities
05/9/202415:00PRNUSAvidity Biosciences Joins Patient and Advocacy Communities..
28/8/202415:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
21/8/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
19/8/202415:00PRNUSAvidity Biosciences Announces Closing of Upsized Public..
15/8/202422:46EDGAR2Form 8-K - Current report
15/8/202422:43EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/8/202402:30PRNUSAvidity Biosciences Announces Pricing of Upsized Public..
13/8/202422:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202423:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202423:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202422:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202422:20EDGAR2Form 8-K - Current report
09/8/202422:05PRNUSAvidity Biosciences Reports Second Quarter 2024 Financial..
09/8/202413:02EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 31,05

La tua Cronologia

NASDAQ
RNA
Avidity Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network